Tissue expression and sero-reactivity of tumor-specific antigens in colorectal cancer

Cancer Letters

Volumn 208, Issue 2, 2004, Pages 197-206

  Gerhardt, Axel ^a   Usener, Dirk ^a   Keese, Michael ^b   Sturm, Jörg ^b   Schadendorf, Dirk ^a   Eichmüller, Stefan ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cancer germline genes; cTAGE; GAGE; MAGE; NY ESO 1

Indexed keywords

ANTIBODY; MELANOMA ANTIGEN; MESSENGER RNA; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL LINE; COLORECTAL CANCER; CONTROLLED STUDY; ENTERITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, NEOPLASM; COLORECTAL NEOPLASMS; HUMANS; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 2442584560     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.11.021     Document Type: Article

References (44)

1. Ferlay J., Bray F., Pisani P., Parkin D. Cancer Incidence, Mortality and Prevalence Wolrdwide, Lyon: IARC, 2001 Version 1.0 IARC CancerBase No. 5. 2000;. http://www.dep.iarcfr/globocan/globocanhtm
2. Benson A.B. III, Choti M.A., Cohen A.M., Doroshow J.H., Fuchs C., Kiel K., et al. NCCN practice guidelines for colorectal cancer. Oncology (Huntingt). 14:2000;203-212
3. Meyers M.O., Sasson A.R., Sigurdson E.R. Locoregional strategies for colorectal hepatic metastases. Clin. Colorectal. Cancer. 3:2003;34-44
4. McAneny D., Ryan C.A., Beazley R.M., Kaufman H.L. Results of a phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer. Ann. Surg. Oncol. 3:1996;495-500
5. Ullenhag G.J., Frodin J.E., Mosolits S., Kiaii S., Hassan M., Bonnet M.C., et al. Immunization of colorectal carcinoma patients with a recombinant canarypox virus expressing the tumor antigen Ep-CAM/KSA (ALVAC-KSA) and granulocyte macrophage colony-stimulating factor induced a tumor-specific cellular immune response. Clin. Cancer Res. 9:2003;2447-2456
6. Conry R.M., Curiel D.T., Strong T.V., Moore S.E., Allen K.O., Barlow D.L., et al. Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients. Clin. Cancer Res. 8:2002;2782-2787
7. Bremers A.J., Andreola S., Leo E., Gallino F., Rini F., Lombardo C., et al. T cell responses in colorectal cancer patients: evidence for class II HLA-restricted recognition of shared tumor-associated antigens. Int. J. Cancer. 88:2000;956-961
8. Nair S.K., Morse M., Boczkowski D., Cumming R.I., Vasovic L., Gilboa E., Lyerly H.K. Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells. Ann. Surg. 235:2002;540-549
9. Nagorsen D., Keilholz U., Rivoltini L., Schmittel A., Letsch A., Asemissen A.M., et al. Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer. Cancer Res. 60:2000;4850-4854
10. Nagorsen D., Scheibenbogen C., Schaller G., Leigh B., Schmittel A., Letsch A., et al. Differences in T-cell immunity toward tumor-associated antigens in colorectal cancer and breast cancer patients. Int. J. Cancer. 105:2003;221-225
11. Engleman E.G., Fong L. Induction of immunity to tumor-associated antigens following dendritic cell vaccination of cancer patients. Clin. Immunol. 106:2003;10-15
12. Renkvist N., Castelli C., Robbins P.F., Parmiani G. A listing of human tumor antigens recognized by T cells. Cancer Immunol. Immunother..50:2001;3-15
13. Dalerba P., Maccalli C., Casati C., Castelli C., Parmiani G. Immunology and immunotherapy of colorectal cancer. Crit. Rev. Oncol. Hematol. 46:2003;33-57
14. Old L.J. Cancer/Testis (CT) antigens - a new link between gametogenesis and cancer. Cancer Immun. 1:2001;1
15. Chen Y.T., Old L.J. Cancer-testis antigens: targets for cancer immunotherapy. Cancer J. Sci. Am. 5:1999;16-17
16. van der Bruggen P., Traversari C., Chomez P., Lurquin C., De Plaen E., van den Eynde B., et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 254:1991;1643-1647
17. De Smet C., Lurquin C., Lethé B., Martelange V., Boon T. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol. Cell. Biol. 19:1999;7327-7335
18. Weiser T.S., Guo Z.S., Ohnmacht G.A., Parkhurst M.L., Tong-On P., Marincola F.M., et al. Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1. J.Immunother. 24:2001;151-161
19. Eichmüller S., Usener D., Dummer R., Stein A., Thiel D., Schadendorf D. Serological detection of cutaneous T-cell lymphoma-associated antigens. 98:2001;629-634
20. Usener D., Schadendorf D., Koch J., Dübel S., Eichmüller S. cTAGE: a cutaneous T-cell lymphoma associated antigen family with tumor-specific splicing. J. Invest Dermatol. 121:2003;198-206
21. Gaugler B., Brouwenstijn N., Vantomme V., Szikora J.P., Van der Spek C.W., Patard J.J., et al. A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma. Immunogenetics. 44:1996;323-330
22. Eichmüller S., Usener D., Jochim A., Schadendorf D. mRNA expression of tumor-associated antigens in melanoma tissues and cell lines. Exp. Dermatol. 11:2002;292-301
23. Usener D., Gerhardt A., Schadendorf D., Eichmüller S. Sero-reactivity against MAGE-A and LAGE-1 proteins in melanoma patients. Br. J. Dermatol. 149:2003;282-288
24. Sahin U., Türeci Ö., Schmitt H., Cochlovius B., Johannes T., Schmits R., Stenner F., et al. Human neoplasms elicit multiple specific immune responses in the autologous host. PNAS. 92:1995;11810-11813
25. Coulie P.G., Weynants P., Lehmann F., Herman J., Brichard V., Wölfel T., et al. Genes coding for tumor antigens recognized by human cytolytic T lymphocytes. J. Immunother. 14:1993;104-109
26. van den Eynde B., Peeters O., De Backer O., Gaugler B., Lucas S., Boon T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182:1995;689-698
27. Mori M., Inoue H., Mimori K., Shibuta K., Baba K., Nakashima H., et al. Expression of MAGE genes in human colorectal carcinoma. Ann. Surg. 224:1996;183-188
28. Chen Y.T., Scanlan M.J., Sahin U., Türeci Ö., Güre A.O., Tsang S., et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. PNAS. 94:1997;1914-1918
29. Lethé B., Lucas S., Michaux L., Smet C.D., Godelaine D., Serrano A., et al. LAGE-1, a new gene with tumor specificity. Int. J. Cancer. 76:1998;903-908
30. Türeci Ö., Chen Y.-T., Sahin U., Güre A.O., Zwick C., Villena C., et al. Expression of SSX genes in human tumors. Int. J. Cancer. 77:1998;19-23
31. Hoon D.S., Yuzuki D., Hayashida M., Morton D.L. Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen. J. Immunol. 154:1995;730-737
32. Fujii S., Huang S., Fong T.C., Ando D., Burrows F., Jolly D.J., et al. Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-gamma retroviral vector in melanoma patients. Cancer Gene Ther. 7:2000;1220-1230
33. Moingeon P. Cancer vaccines. Vaccine. 19:2001;1305-1326
34. Bergmann-Leitner E.S., Abrams S.I. Influence of interferon gamma on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8+ cytotoxic T lymphocyte attack. Cancer Immunol. Immunother. 49:2000;193-207
35. Hasegawa H., Mori M., Haraguchi M., Ueo H., Sugimachi K., Akiyoshi T. Expression spectrum of melanoma antigen-encoding gene family members in colorectal carcinoma. Arch. Pathol. Lab. Med. 122:1998;551-554
36. Inoue H., Mori M., Li J., Mimori K., Honda M., Nakashima H., et al. Human esophageal carcinomas frequently express the tumor-rejection antigens of MAGE genes. Int. J. Cancer. 63:1995;523-526
37. De Backer O., Arden K.C., Boretti M., Vantomme V., De Smet C., Czekay S., et al. Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. Cancer Res. 59:1999;3157-3165
38. Eichmüller S., Usener D., Thiel D., Schadendorf D. Tumor-specific antigens in cutaneous T-cell lymphoma: expression and sero-reactivity. Int. J. Cancer. 104:2003;482-487
39. Scanlan M.J., Welt S., Gordon C.M., Chen Y.T., Gure A.O., Stockert E., et al. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. Cancer Res. 62:2002;4041-4047
40. Stockert E., Jäger E., Chen Y.T., Scanlan M.J., Gout I., Karbach J., et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J. Exp. Med. 187:1998;1349-1354
41. Serrano A., Lethé B., Delroisse J.M., Lurquin C., De Plaen E., Brasseur F., et al. Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA libraries. Int. J. Cancer. 83:1999;664-669
42. Weynants P., Lethé B., Brasseur F., Marchand M., Boon T. Expression of mage genes by non-small-cell lung carcinomas. Int. J. Cancer. 56:1994;826-829
43. Scarcella D.L., Chow C.W., Gonzales M.F., Economou C., Brasseur F., Ashley D.M. Expression of MAGE and GAGE in high-grade brain tumors: a potential target for specific immunotherapy and diagnostic markers. Clin. Cancer Res. 5:1999;335-341
44. Türeci O., Sahin U., Schobert I., Koslowski M., Schmitt H., Schild H.J., et al. The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res. 56:1996;4766-4772